2012
Northern Territory poisons and dangerous drugs act (2012)
Northern Territory Government
2011
Australian Crime Commission (2011)
Illicit drug data report 2009-10.
Canberra: Australian Crime Commission
Australian Institute of Health and Welfare (2011)
National opioid pharmacotherapy statistics annual data collection: 2010 report.
Canberra: Australian Institute of Health and Welfare
Australian Institute of Health and Welfare (2011)
Substance use among Aboriginal and Torres Strait Islander people.
Canberra: Australian Institute of Health and Welfare
Harrod ME, Ward J, Graham S, Butler T (2011)
Australian prisons: the key to closing the gap and ensuring HIV remains low in Aboriginal and Torres Strait Islander communities.
HIV Australia; 9(1): 17-19
Kratzmann M, Mitchell E, Ware J, Banach L, Ward J, Ryan J, Sutton L, Griffiths P, Saunders M (2011)
Injecting drug use and associated harms among Aboriginal Australians.
Canberra: Australian National Council on Drugs
The project Injecting drug use and associated harms among Aboriginal Australians was undertaken by Anex and the
National Aboriginal Community Controlled Health Organisation (NACCHO), and commissioned by Australian National Council on Drugs (ANCD). The findings from the project are summarised in this report. Copies can be obtained from the ANCD Secretariat or the ANCD website.
Abstract adapted from ANCD
Ness A, Payne J (2011)
Patterns of mephedrone, GHB, Ketamine and Rohypnol use among police detainees: findings from the DUMA program.
Canberra: Australian Institute of Criminology
Stafford J, Burns L (2011)
Australian drug trends 2010: findings from the Illicit Drug Reporting System (IDRS).
: National Drug and Alcohol Research Centre, University of New South Wales
Ward J, Topp L, Iversen J, Wand H, Akre S, Kaldor J, Maher L (2011)
Higher HCV antibody prevalence among Indigenous clients of needle and syringe programs.
Australian and New Zealand Journal of Public Health; 35(5): 234-245
Watkins RE, Mak DB, Connelly C (2011)
Identifying high risk groups for sexually transmitted infections and blood borne viruses upon admission to prison in Western Australia.
Rural and Remote Health; 11: 1621
Retrieved 16 March 2011 from http://www.rrh.org.au/publishedarticles/article_print_1621.pdf
2010
Australian Department of Health and Ageing (2010)
Sixth national HIV strategy 2010-2013.
Canberra: Department of Health and Ageing, Australia
Australian Department of Health and Ageing (2010)
Third national Aboriginal and Torres Strait Islander blood borne viruses and sexually transmissible infections strategy 2010 – 2013.
Canberra: Department of Health and Ageing, Australia
The Third National Aboriginal and Torres Strait Islander Blood Borne Viruses and Sexually Transmissible Infections Strategy was released in March 2010. It is one of a set of five national strategies aimed at reducing the transmission of sexually transmissible infections (STIs) and blood borne viruses (BBVs) and their morbidity, mortality and personal and social impacts.
The strategy highlights ongoing challenges in Aboriginal and Torres Strait Islander communities relating to STIs and BBVs. These include:
- sustained and unacceptably high rates of bacterial STIs in many remote communities
- the rate of acquisition of HIV and viral hepatitis through injecting drug use
- ongoing incidence of HIV infections among men who have sex with men
- lack of access for many communities to culturally appropriate primary health care services.
The new priority action areas identified in the strategy are:
- annual, routine and systematic testing, treatment and follow-up for bacterial STIs of sexually active Aboriginal and Torres Strait Islander young people
- increased access to treatment for Aboriginal and Torres Strait Islander young people who test positive to bacterial STIs;
- increased primary prevention activities that seek to reduce the number of new cases of HIV and viral hepatitis among Aboriginal and Torres Strait Islander people who inject drugs
- competent and accredited workforces consistent across all jurisdictions to address the scope of work outlined in the strategy.
Australian Indigenous HealthInfoNet abstract
Australian Department of Health and Ageing (2010)
Third national hepatitis C strategy 2010 - 2013.
Canberra: Department of Health and Ageing, Australia
Australian Institute of Health and Welfare (2010)
National opioid pharmacotherapy statistical annual data collection: 2009 report : [2010 data guide included].
Canberra: Australian Institute of Health and Welfare
Australian Institute of Health and Welfare (2010)
National opioid pharmacotherapy statistics annual data collection: 2009 report.
Canberra: Australian Institute of Health and Welfare
Boonwaat L, Haber PS, Levy MH, Lloyd AR (2010)
Establishment of a successful assessment and treatment service for Australian prison inmates with chronic hepatitis C.
Medical Journal of Australia; 192(9): 496-500
Department of Health and Ageing (2010)
National needle and syringe programs strategic framework 2010-2014.
Canberra: Department of Health and Ageing, Australia
Hickey S, McIlwraith F, Alati R (2010)
Licit drug use by ecstasy users, nationally and in Queensland: are there gender differences?.
Sydney: National Drug & Alcohol Research Centre
Indig D, McEntyre E, Page J, Ross B (2010)
2009 NSW inmate health survey: Aboriginal health report.
Sydney: Justice Health
Iversen J, Topp L, Shying K, Maher L (2010)
Australian NSP Survey National Data Report 2005-2009: prevalence of HIV, HCV and injecting and sexual behaviour among IDUs at Needle and Syringe Programs.
Sydney: National Centre in HIV Epidemiology and Clinical Research
Iversen J, Topp L, Maher L (2010)
Drug injection trends among participants in the Australian Needle and Syringe Program Survey (ANSPS), 2005 - 2009.
Sydney: National Drug & Alcohol Research Centre
Iversen J, Wand H, Gonnermann A, Maher L (2010)
Gender differences in hepatitis C antibody prevalence and risk behaviours amongst people who inject drugs in Australia 1998-2008.
International Journal of Drug Policy; Article in Press(doi:10.1016/j.drugpo.2010.04.004): 1-6
Kwan K, Mak D, Giele C, Bastian L, Bevan J, Greville H, Lilley G (2010)
The epidemiology of notifiable sexually transmitted infections and blood-borne viruses in Western Australia 2008.
Perth, WA: Public Health, Western Australia
Larney S (2010)
Does opioid substitution treatment in prisons reduce injecting-related HIV risk behaviours? A systematic review.
Addiction; 105 Issue 2, Pages 216 - 223(2, Pages 216 - 223): 216 - 223
Mapfumo L, Waples-Crowe P, Ware J (2010)
Action research - addressing HIV risks related to injecting drug use in Victorian Aboriginal communities.
Melbourne: Anex
McAtamney A, Willis K (2010)
Policing cannabis and other illicit substances in remote Indigenous Australian communities.
Retrieved from http://ncpic.org.au/ncpic/publications/aic-bulletins/article/policing-cannabis-and-other-illicit-substances-in-remote-indigenous-australian-communities
McMahon T, Moreton RJ, Luisi BN (2010)
Guarding against an HIV epidemic within an Aboriginal community and cultural framework; lessons from NSW.
New South Wales Public Health Bulletin; 21(4): 83-85
National Centre in HIV Epidemiology & Clinical Research (2010)
Bloodborne viral and sexually transmitted infections in Aboriginal and Torres Strait Islander people: surveillance and evaluation report 2010.
Sydney, NSW: National Centre in HIV Epidemiology & Clinical Research, University of New South Wales
This annual report provides statistical information on the incidence of sexually transmissible infections (STIs) and bloodborne viruses (BBVs) among Aboriginal and Torres Strait Islander peoples and other Australians. In most instances, the data utilised in this report are to the end of 2009 and relate specifically to chlamydia, donovanosis, gonorrhoea, syphilis, HIV, hepatitis B, and hepatitis C. Consistent with previous surveillance reports, this report reveals that Indigenous peoples continue to experience significantly higher rates of STIs and BBVs when compared with non-Indigenous Australians. Numerous factors are identified as contributing to the higher rates of STIs and BBVs in the Indigenous population including: less access to health services; shortage of clinical staff; transmission dynamics; high rates of screening; a younger, more mobile population; socioeconomic disadvantage; shame and historical factors; and mainstream STI and BBV social marketing messages. Ultimately this report seeks to encourage further dialogue on minimising the risks associated with the transmission of STIs and BBVs among Indigenous peoples, as well as the resultant personal and social implications.
Australian Indigenous HealthInfoNet abstract
National Centre in HIV Epidemiology & Clinical Research (2010)
HIV, viral hepatitis and sexually transmissible infections in Australia: annual surveillance report 2010.
Sydney, NSW: National Centre in HIV Epidemiology & Clinical Research, University of New South Wales
Smith G, White V (2010)
Use of tobacco, alcohol, and over-the-counter and illicit substances among Indigenous students participating in the Australian Secondary Students Alcohol and Drug Survey 2008.
Canberra: Department of Health and Ageing, Australia
Stafford J, Burns L (2010)
Australian drug trends 2009: findings from the Illicit Drug Reporting System (IDRS).
Sydney: National Drug and Alcohol Research Centre, University of New South Wales
2009
Australian Institute of Health and Welfare (2009)
National opioid pharmacotherapy statistics annual data collection: 2008 report.
Canberra: Australian Institute of Health and Welfare
Craib KJP, Spittal PM, Patel SH, Christian WM, Moniruzzaman A, Pearce ME, Demerais L, Sherlock C, Schechter MT (2009)
Prevalence and incidence of hepatitis C virus infection among Aboriginal young people who use drugs: results from the Cedar Project.
Open Medicine; 3(4): e220-e227
Hepatitis Australia, National Aboriginal Community Controlled Health Organisation, Aldo Spina Consultancy Services (2009)
Mapping and scoping of hepatitis C education and prevention activities in Aboriginal and Torres Strait Islander communities: survey of Aboriginal community controlled health services.
Canberra: Hepatitis Australia
Lintzeris N (2009)
The new wave of opioid dependence.
Of Substance; 7(3): 10-11
McNally S, Latham R (2009)
Recognising and responding to hepatitis C in Indigenous communities in Victoria: a research project exploring barriers to hepatitis C treatment.
Melbourne: Australian Research Centre in Sex Health and Society
This report presents the outcomes of a study conducted in Victoria that investigated access to hepatitis C treatment services among Indigenous people. The research study evolved out of concern for the high rate of hepatitis C in the Indigenous population and the low uptake of treatment and care. Through interviews with service providers and Indigenous people, a number of treatment barriers were revealed, namely the low priority afforded to hepatitis C due to competing co-morbidities. Shame and lack of knowledge about hepatitis C among Indigenous people and health care workers, were also identified as major barriers to treatment. Several suggestions and recommendations have been offered for addressing these treatment barriers, including placing greater emphasis on eating well and reducing alcohol intake.
Australian Indigenous HealthInfoNet abstract
Stafford J, Sindicich N, Burns L, Cassar J, Cogger S, de Graaff B, George J, Moon C, Phillips B, Quinn B, White N (2009)
Australian Drug Trends 2008: findings from the Illicit Drug Reporting System (IDRS).
Sydney: National Drug and Alcohol Research Centre, University of New South Wales
Tetstall E, Liu AJ, An EI, Canalese J, Nanan R (2009)
Pregnancy and neonatal characteristics of opioid-dependent Indigenous Australians: a rural and metropolitan comparison.
Australian and New Zealand Journal of Obstetrics and Gynaecology; 49(3): 279-84
Wilson D, Kwon A, Anderson J, Thein R (2009)
Return on investment 2: evaluating the cost-effectiveness of needle and syringe programs in Australia.
Sydney: Department of Health and Ageing, Australia
2008
Australian Indigenous HealthInfoNet (2008)
A brief summary of hepatitis C among Indigenous Australians.
Retrieved from http://www.healthinfonet.ecu.edu.au/infectious-conditions/hepatitis/reviews/our-review-c
Australian Institute of Health and Welfare (2008)
National opioid pharmacotherapy statistics annual data collection: 2007 report.
Canberra: Australian Institute of Health and Welfare
Catto M, Thomson N (2008)
Review of illicit drug use among Indigenous peoples.
Australian Indigenous HealthBulletin; 8(4): 1-32
Degenhardt L, Kinner SA, Roxburgh A, Black E, Bruno R, Fetherston J, Fry CL (2008)
Drug use and risk among regular injecting drug users in Australia: does age make a difference?.
Drug and Alcohol Review; 27(4): 357-360
Drug and Alcohol Office (WA) (2008)
Aboriginal blood-borne virus scoping project literature review.
Perth: Drug and Alcohol Office (WA)
The 'Aboriginal Blood-Borne Virus Scoping Project' was undertaken to investigate the enablers and barriers of accessing needle and syringe programs in Kalgoorlie and the south-west for Aboriginal people who inject drugs (APWIDs). The 'Sexual Health and Blood Borne Virus Program' from the Department of Health (WA) funded the Alcohol and Drug Office to conduct the scoping project.
The scoping project was undertaken in response to the National Aboriginal and Torres Strait Islander Sexual Health Strategy 2005-2008 (2005), identifying HIV/AIDS and Hepatitis B and C as significant health issues for Indigenous people who inject drugs, and the need to strengthen harm reduction programs in this area, as well as recent data identifying a higher number of HIV diagnoses as a result of injecting drug use among the Indigenous population compared to the non-Indigenous population, and greater rates of Hepatitis B and C diagnoses as a result of injecting drug use among the Indigenous population compared to the non-Indigenous population.
The 'Aboriginal Blood-Borne Virus Scoping Project Literature Review' was undertaken as a compendium to the project. The review examined recent national and local studies of Indigenous injecting drug use and associated harm reduction strategies, and related projects and initiatives.
Australian Indigenous HealthInfoNet abstract
Teesson M, Mills K, Ross J, Darke S, Williamson A, Harvard A (2008)
The impact of treatment on 3 years' outcome for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).
Addiction; 103(1): 80-88
URBIS (2008)
A review of enablers and barriers of Indigenous drug users accessing needle and syringe programs - a report for the COAG Multilateral Group on needle and syringe programs.
Canberra: Department of Health and Ageing, Australia
2007
Butler T, Boonwaat L, Hailstone S, Falconer T, Lems P, Ginley T, Read V, Smith N, Levy M, Dore G, Kaldor J (2007)
The 2004 Australian prison entrants' blood-borne virus and risk behaviour survey.
Australian and New Zealand Journal of Public Health; 31(1): 44-50
Drug and Alcohol Office (2007)
Western Australia Illicit Amphetamine Summit July 2007: background paper.
Perth: Drug and Alcohol Office
Gibson A, Degenhardt L, Mattick RP, Ali R, White J, O'Brien S (2007)
Exposure to opioid maintenance treatment reduces long-term mortality.
Addiction; 103(3): 462–468
Levy MH, Treloar C, McDonald RM, Booker N (2007)
Prisons, hepatitis C and harm minimisation.
Medical Journal of Australia; 186(12): 647-649
National Drug Strategy (2007)
National amphetamine-type stimulant strategy background paper.
Canberra: National Drug Research Institute and Australian Institute of Criminology
Onemda VicHealth Koori Health Unit (2007)
Evidence base for STI/BBV prevention and treatment for Koori people in prison.
Melbourne: Onemda VicHealth Koori Health Unit
2006
Australian Bureau of Statistics (2006)
National Aboriginal and Torres Strait Islander Health Survey: Australia, 2004-05.
Canberra: Australian Bureau of Statistics
This summary of results from the 2004-05 National Aboriginal and Torres Strait Islander Health Survey provides information about health status, health actions, and lifestyle factors, of Indigenous peoples. There are comparisons with the 1995 and 2001 National Health Surveys and the 2002 National Aboriginal Torres Strait Islander Social Survey.
Australian Indigenous HealthInfoNet abstract
Cao W, Treloar C (2006)
Comparison of needle and syringe programme attendees and non-attendees from a high-using area in Sydney, New South Wales.
Drug and Alcohol Review; 25(5): 439-444
Delahunty B, Putt J (2006)
The policing implications of cannabis, amphetamine and other illicit drug use in Aboriginal and Torres Strait Islander communities.
Canberra: Australian Institute of Aboriginal and Torres Strait Islander Studies and Australian Government Department of Health and Ageing
This report highlights the issues associated with the policing of cannabis, amphetamine and other illicit drug use in Indigenous rural and remote communities. It also focuses on the role of police in their endeavour to reduce drug-related harm.
Australian Indigenous HealthInfoNet abstract
Hepatitis C Virus Projections Working Group (2006)
Estimates and projections of the hepatitis C virus epidemic in Australia 2006.
Canberra: Ministerial Advisory Committee on AIDS, Sexual Health and Hepatitis C Sub-Committee
Miller ER (2006)
HCV infection in South Australian prisoners : prevalence, transmission, risk factors and prospects for harm reduction.
Unpublished Doctor of Philosophy thesis, University of Adelaide: Adelaide
Nicholas R (2006)
The current amphetamine situation in Australasia - implications for policing.
Marden, SA: Australasian Centre for Policing
Riddell R, Neilssen O, Butler T, MacDonald C, Starmer G (2006)
The relationship between amphetamine use, crime and psychiatric disorder among prisoners in New South Wales.
Psychiatry, Psychology and Law; 13(2): 160-165
Shearer J, White B, Gilmour S, Wodak AD, Dolan KA (2006)
Hair analysis underestimates heroin use in prisoners.
Drug and Alcohol Review; 25(5): 425-431
Thein H-H, Butler T, Krahn M, Rawlinson W, Levy MH, Kaldor JM, Dore GJ (2006)
The effect of hepatitis C virus infection on health-related quality of life in prisoners.
Journal of Urban Health; 83(2): 275-288
Williams N, Nasir R, Smither G, Troon S (2006)
Providing opioid substitution treatment to Indigenous heroin users within a community health service setting in Adelaide.
Drug and Alcohol Review; 25(3): 227-232
Bibliography
Health promotion
Yarning places
message stick
Programs
Organisations
Conferences
Courses
Funding
Jobs
Print
